✦ LIBER ✦

5089 Shorter Overall Survival (OS) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T)± chemotherapy (CT) and overexpressing HER3 by immunohistochemistry (IHC)

✍ Scribed by S. Gori; A. Sidoni; M. Colozza; M.G. Mameli; D. Fenocchio; E. Minenza; J. Foglietta; L. Stocchi; V. De Angelis; L. Crinò

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2128 POSTER PTEN, EGFR, MAPK and Akt sta

✍ S. Gori; V. De Angelis; A. Sidoni; M. Colozza; I. Ferri; D. Fenocchio; V. Ludovi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

412 POSTER High incidence of brain metas

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 280 KB

490 Long term survival and incidence of

✍ V. Diéras; M.N. Guilhaume; M. Fall; J.Y. Pierga; P. Beuzeboc; P. Cottu; C. Simon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB